Both industry supporters (pharmaceutical, biotech and medical devices companies) and Continuing Medical Education providers have been affected by changes in the rules governing commercial support of CME programs. Industry support of CME has been scrutinized by Congress. The ACCME has issued new guidance, as well as a “Call for Comment,” on the issue of industry funding. The new PhRMA Code specifically addresses CME funding, as do certain state laws, most notably the new Massachusetts law governing relationships between industry and physicians.
Life sciences companies need to keep abreast of these changes to make sure their internal policies are consistent with the latest law and guidance. CME providers need to be current as well, both to maintain their accreditation status and to be sure they are able to remain competitive in the current environment. In this audio conference, we take a look at the new rules and what sponsors and providers need to do to comply.
The New Rules for Continuing Medical Education is being presented by Maria D. Buckley, with Nutter McClennen & Fish LLP and airs on Thursday, January 8, 2009. For more details or to register for this conference, please visit our site www.fxconferences.com
